NCT06759831 Clinical and Immunological Outcomes of Living and Deceased Donor Transplantation
| NCT ID | NCT06759831 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Transplant Recipient (Kidney) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,293 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2033-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,293 participants in total. It began in 2024-11-01 with a primary completion date of 2033-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a retrospective, prospective, single-centre, non-pharmacological observational study. The primary objective is to investigate the long-term prognosis of the kidney transplant function of different types of donors.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years. * Kidney transplant recipient from any donor. * Acquisition of Informed Consent to study participation and data processing. Exclusion Criteria: \-
Contact & Investigator
Giorgia Comai, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06759831 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Transplant Recipient (Kidney). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06759831 currently recruiting?
Yes, NCT06759831 is actively recruiting participants. Contact the research team at giorgia.comai@aosp.bo.it for enrollment information.
Where is the NCT06759831 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06759831 clinical trial?
NCT06759831 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Giorgia Comai, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 1,293 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.